Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)
N Asou, K Adachi, U Tamura, et al.
International Journal of Hematology
|
January 14, 1999
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)
M Tanimoto, S Miyawaki, T Ino, et al.
International Journal of Hematology
|
December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group
T Ueda, S Miyawaki, N Asou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
R Ohno, S Miyawaki, K Hatake, et al.
Leukemia Research
|
August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group
K Ohnishi, M Tomonaga, N Kamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group
N Asou, K Adachi, J Tamura, et al.
Leukemia
|
September 16, 2017
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG
T Sakura, F Hayakawa, I Sugiura, et al.
Leukemia
|
July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi, T Kyo, K Naito, et al.
International Journal of Hematology
|
September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group
S Miyawaki, M Tanimoto, T Kobayashi, et al.
International Journal of Hematology
|
April 1, 1997
Case-control study of leukemia and diagnostic radiation exposure
H Yuasa, N Hamajima, R Ueda, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Cancer Chemotherapy and Pharmacology
|
October 6, 2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)
N Asou, K Adachi, U Tamura, et al.
International Journal of Hematology
|
January 14, 1999
Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)
M Tanimoto, S Miyawaki, T Ino, et al.
International Journal of Hematology
|
December 10, 1998
Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group
T Ueda, S Miyawaki, N Asou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
R Ohno, S Miyawaki, K Hatake, et al.
Leukemia Research
|
August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group
K Ohnishi, M Tomonaga, N Kamada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 1998
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group
N Asou, K Adachi, J Tamura, et al.
Leukemia
|
September 16, 2017
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG
T Sakura, F Hayakawa, I Sugiura, et al.
Leukemia
|
July 3, 2002
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi, T Kyo, K Naito, et al.
International Journal of Hematology
|
September 25, 1999
No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group
S Miyawaki, M Tanimoto, T Kobayashi, et al.
International Journal of Hematology
|
April 1, 1997
Case-control study of leukemia and diagnostic radiation exposure
H Yuasa, N Hamajima, R Ueda, et al.
Page
of 13